Latest Press Releases | MSF Access

Latest Press Releases

MSF Pharmacy Technician Toueng Sreymon distributes Hepatitis C meds at the MSF Hepatitis C clinic at Preah Kossamak Hospital in Phnom Penh, Cambodia, 18, April 2017. Photograph by Todd Brown

Photograph by Todd Brown

Press release |

27 March 2017

MSF joins Europe-wide action challenging patent on key hepatitis C drug

Bacteria culture tubes for BACTEC™ MGIT™ 960 Mycobacterial detection system in the National TB Reference Laboratory. This device helps growing and detecting TB bacteria and determining drug resistances. Government Hospital, Mbabane, Swaziland. Photograph by Alexis Huguet

Photograph by Alexis Huguet

Press release

Press release |

24 March 2017

MSF urges pharma firms to release clinical data on TB drug

3 min

Eight-week-old Mohamed Zakari receives his first dose of the oral rotavirus vaccine (or the placebo). Eight weeks is the cut-off age. If Hadiza had come one day later, they would have had to be excluded from the clinical trial in order to comply with the medical protocol. Mohamed will receive the second and third doses of the vaccine at 10 and 14 weeks, respectively. Photograph by Séverine Bonnet

Photograph by Séverine Bonnet

Press release

Press release |

23 March 2017

Vaccines

Innovative vaccine could prevent thousands of child deaths from diarrhoea

3 min

Sinethemba takes her daily regimen for XDR-TB at 10am each day. She also takes two additional delamanid tablets at night. She is 16 years old, lives with her grandmother, Vuyisiwa Madubela, and four other family members in a two-bedroomed home in Zone C29, Khayelitsha, Western Cape, South Africa. Her grandmother’s determination and love, combined with receiving a six-month trial of one the newest DR-TB drugs on the market likely saved her life this year.

Photograph by Sydelle Willow Smith

Press release |

23 March 2017

Fewer than 5% of people in need are treated with new TB drugs, nearly four years after their approval

Nearly 2,000 People Living With HIV along with MSF & other civil society organisations rallied in the streets of New Delhi at the start of the EU-India summit. They warned that harmful provisions in a trade deal being negotiated between the EU and India could severely hinder access to affordable medicine for people in developing countries.

Photograph by Siddharth Singh

Press release |

22 March 2017

Intellectual property and trade

India

India–EFTA trade talks may make medicines more expensive

5 min

Goderdzi Rajabishvili, an ambulatory patient at the National Centre for Tuberculosis and Lung Disease in Georgia’s capital, Tbilisi, receives his twice-daily infusion of imipenem, an antibiotic used to treat MDR-TB.

Photograph by Daro Sulakauri

Press release |

06 March 2017

Georgia

endTB partnership launches clinical trial to target toughest strains of tuberculosis

Treatment of a Kala azar-HIV co-infected patient lasts for almost a month. The duration of long admission impacts the individual and their families, often taking them away from their livelihoods or necessitating a caretaker’s presence. Pictured here is a patient with her daughter in MSF’s Kala azar-HIV ward in Patna, Bihar.

Photograph by Javeed Shah

Press release |

02 March 2017

Research and development

United States of America

US Lawmakers fail to fix flawed PRV program intended to promote new medicines for neglected diseases

3 min

Antibiotic Resistance Running Out Options

Photograph by Vivian Lee

Press release

Press release |

27 February 2017

Antimicrobial resistance

MSF response to WHO antibiotic-resistant "priority pathogens" list

2 min